Don’t forget you can visit MyAlerts to manage your alerts at any time.
By P.J. D'Annunzio | August 28, 2018
Insys, the manufacturer of the fentanyl drug Subsys, used most commonly for cancer patients, encouraged doctors to prescribe the painkiller for uses other than those approved by the FDA, Aetna alleged.
1 minute read
By Amanda Bronstad | August 24, 2018
Lawyers attempting to negotiate a global settlement of lawsuits brought over the opioid epidemic aren't representing a key group: babies who have been born addicted to prescription painkillers.
1 minute read
By Roy Strom | August 23, 2018
A Chicago jury's $3 million award to the widow of former Reed Smith partner Stewart Dolin has been dismissed after an appeals court held that GlaxoSmithKline was prevented by the FDA from adding a suicide warning to the label for Paxil.
1 minute read
By Curt Anderson | August 22, 2018
Patricia Rodgers estimates she and her husband lost over $100,000, including about $20,000 spent on attending Herbalife events.
1 minute read
By Jenna Greene | August 21, 2018
When you've got a 6-year-old who suddenly can't breathe, the notion of an EpiPen as a profit center becomes obscene.
1 minute read
By Charles Toutant | August 21, 2018
The court designated all cases involving allegations of injuries from Taxotere as multicounty litigation, and assigned the group to Superior Court Judge James Hyland in Middlesex County for centralized case management.
1 minute read
By Andrew Denney | August 17, 2018
Evan Greebel, a former partner at Kaye Scholer and Katten Muchin Rosenman, is headed to prison after working with disgraced pharmaceutical executive Martin Shkreli to defraud investors.
1 minute read
By Charles Toutant | August 16, 2018
"If counsel is now 'scared off' by the prospect of paying for trial, counsel should not have undertaken the representation of plaintiff in the first instance," U.S. Magistrate Judge Joel Schneider said.
1 minute read
By Amanda Bronstad | August 15, 2018
Opioid manufacturers and one distributor say the complaint against them lacks specifics to back up deceptive trade practices and public nuisance claims. But the amicus briefs said none of that mattered because a state has a “unique role” in the opioid crisis.
1 minute read
By Amanda Bronstad | August 15, 2018
Opioid manufacturers and one distributor say the complaint against them lacks specifics to back up deceptive trade practices and public nuisance claims. But the amicus briefs said none of that mattered because a state has a “unique role” in the opioid crisis.
1 minute read
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS